Cargando…
Bilirubin Prevents Atherosclerotic Lesion Formation in Low‐Density Lipoprotein Receptor‐Deficient Mice by Inhibiting Endothelial VCAM‐1 and ICAM‐1 Signaling
BACKGROUND: Numerous epidemiological studies support an inverse association between serum bilirubin levels and the incidence of cardiovascular disease; however, the mechanism(s) by which bilirubin may protect against atherosclerosis is undefined. The goals of the present investigations were to asses...
Autores principales: | Vogel, Megan E., Idelman, Gila, Konaniah, Eddy S., Zucker, Stephen D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532999/ https://www.ncbi.nlm.nih.gov/pubmed/28365565 http://dx.doi.org/10.1161/JAHA.116.004820 |
Ejemplares similares
-
ICAM-1 Clustering on Endothelial Cells Recruits VCAM-1
por: van Buul, Jaap D., et al.
Publicado: (2010) -
Bilirubin inhibits the up-regulation of inducible nitric oxide synthase by scavenging reactive oxygen species generated by the toll-like receptor 4-dependent activation of NADPH oxidase
por: Idelman, Gila, et al.
Publicado: (2015) -
VCAM1 and ICAM1 expression in oral lichen planus
por: Seyedmajidi, Maryam, et al.
Publicado: (2013) -
Proanthocyanidins, from Ribes nigrum leaves, reduce endothelial adhesion molecules ICAM-1 and VCAM-1
por: Garbacki, N, et al.
Publicado: (2005) -
Maprotiline inhibits LPS-induced expression of adhesion molecules (ICAM-1 and VCAM-1) in human endothelial cells
por: Rafiee, Laleh, et al.
Publicado: (2016)